Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg
GlobeNewswire - Tue Dec 16, 2:52PM CST
RedChip Companies, Inc. ("RedChip"
OPXA: 0.71 (-0.03), ATNM: 5.63 (-0.02), AKER: 2.99 (+0.01), CGIX: 6.29 (+0.12)
Insider Trading Alert - AMT, LNC And CGIX Traded By Insiders
at The Street - Tue Dec 16, 11:29AM CST
Stocks with insider trader activity include AMT, LNC and CGIX
AMT: 95.78 (-1.67), LNC: 53.95 (-0.86), CGIX: 6.29 (+0.12)
Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors
GlobeNewswire - Tue Dec 16, 6:30AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 6.29 (+0.12)
Insider Trading Alert - BYD, CGIX And AAWW Traded By Insiders
at The Street - Mon Dec 15, 10:00AM CST
Stocks with insider trader activity include BYD, CGIX and AAWW
AAWW: 45.12 (-0.79), BYD: 10.75 (-0.47), CGIX: 6.29 (+0.12)
Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders
at The Street - Fri Dec 12, 10:15AM CST
Stocks with insider trader activity include CGIX, NBY and BIOA
BIOA: 8.15 (unch), NBY: 0.65 (-0.01), CGIX: 6.29 (+0.12)
Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders
at The Street - Thu Dec 11, 12:15PM CST
Stocks with insider trader activity include CDW, CGIX and RDNT
RDNT: 8.59 (+0.17), CGIX: 6.29 (+0.12), CDW: 33.26 (+0.05)
Cancer Genetics (CGIX) Looks Good: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:25AM CST
Cancer Genetics (CGIX) was a big mover last session, with shares rising just over 8% on the day.
Q: 57.17 (+0.12), CRL: 61.77 (-0.49), ICLR: 51.20 (+0.76), CGIX: 6.29 (+0.12)
Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations
GlobeNewswire - Wed Dec 10, 6:30AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 6.29 (+0.12)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:45AM CST
BLUE: 85.87 (-0.33), SC: 17.76 (+0.04), ANV: 0.85 (+0.07), UTIW: 10.74 (-0.06), AKAO: 11.97 (+0.05), CLDN: 17.76 (+0.03), MZOR: 14.12 (-0.49), NBG: 1.80 (-0.03), TTI: 5.44 (+0.42), TPLM: 4.57 (+0.59), CGIX: 6.29 (+0.12), LCI: 42.70 (-1.35), SAVE: 68.70 (+0.11), PQ: 3.25 (-0.01), AFMD: 5.43 (-0.25), ENSV: 1.44 (-0.02), CTC: 0.64 (-0.01), CONN: 14.15 (-1.63), PDCE: 34.04 (+2.10), KPTI: 31.07 (-0.82)
Cancer Genetics, Inc. to Receive $530,000 Through New Jersey Technology Business Tax Program
GlobeNewswire - Tue Dec 09, 8:12AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 6.29 (+0.12)
Cancer Genetics, Inc. Announces Launch of Targeted Next Generation Sequencing Based Panel for Chronic Lymphocytic Leukemia, Focus::CLL
GlobeNewswire - Mon Dec 08, 6:30AM CST
-- Only NGS-based panel for CLL that offers information for patient risk stratification, disease management, and treatment selection
CGIX: 6.29 (+0.12)
RedChip Receives Top Praise for Its Performance
GlobeNewswire - Thu Dec 04, 8:45AM CST
RedChip Companies, Inc. ("RedChip"
CGIX: 6.29 (+0.12)
Cancer Genetics Inc. Announces the Appointments of Dr. Howard McLeod and Geoffrey Harris to Its Board of Directors
GlobeNewswire - Wed Dec 03, 4:41PM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"
CGIX: 6.29 (+0.12)
Cancer Genetics, Inc. to Present at 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Mon Dec 01, 6:55AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 6.29 (+0.12)
Cancer Genetics, Inc. to Present at American Society of Hematology (ASH) Annual Meeting
GlobeNewswire - Mon Nov 17, 6:50AM CST
-- Cancer Genetics will present two posters on diffuse large B-cell lymphoma (DLBCL), the most common form of B-cell cancers.
CGIX: 6.29 (+0.12)
Cancer Genetics, Inc. Recognized in Deloitte's 2014 Technology Fast 500(TM) Awards
GlobeNewswire - Fri Nov 14, 7:06AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the company"
CGIX: 6.29 (+0.12)
Cancer Genetics Inc to Present at Canaccord Genuity Medical Technology & Diagnostics Conference
GlobeNewswire - Thu Nov 13, 6:55AM CST
Cancer Genetics, Inc., (Nasdaq:CGIX) an emerging leader in DNA-based cancer diagnostics, announced today that the company's CEO, Panna Sharma, will present at the upcoming Canaccord Genuity Medical Technology & Diagnostics Conference. The event, which will be held at the Westin Grand Central in New York on Thursday, November 20, will profile over 80 public and private med-tech and diagnostic companies.
CGIX: 6.29 (+0.12)
Cancer Genetics wins second patent for FHACT test to improve cervical cancer detection for up to 2m women in the US each year
M2 - Wed Nov 12, 7:02AM CST
Cancer diagnostics company Cancer Genetics (NasdaqCM:CGIX) disclosed on Tuesday the receipt of the second US patent (US Patent No. 8,883,414) for its proprietary FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer detection in patients.
CGIX: 6.29 (+0.12)
RedChip Issues Research Note on Cancer Genetics
GlobeNewswire - Wed Nov 12, 7:00AM CST
RedChip Companies, Inc., today announced it has issued a research note on Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers.
CGIX: 6.29 (+0.12)
Cancer Genetics Inc to Present on Company's Targeted Next-Generation Sequencing Panels at AMP
GlobeNewswire - Wed Nov 12, 6:55AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"
CGIX: 6.29 (+0.12)